Fig. 9From: Integrative analysis and experiments to explore angiogenesis regulators correlated with poor prognosis, immune infiltration and cancer progression in lung adenocarcinomaExternal and experimental validation of COL5A2 and EPHB2 expression levels and independent prognostic value in LUAD patients. A Oncomine database showing the transcriptomic aberration of COL5A2 and EPHB2 in pancancer tissues. B, C The GEPIA database exhibiting the transcriptomic aberration of COL5A2 and EPHB2 in LUAD tissues and nontumor tissues. D, E IHC assay indicates the protein expression levels of COL5A2 and EPHB2 in LUAD tissues and nontumor tissues. F, G Kaplan–Meier Plotter database revealed the independent prognostic value of COL5A2 (F) and EPHB2 (G) in lung cancer patients. H, I TIMER database showing the correlation between immune cell infiltration and COL5A2 (H) and EPHB2 (I) in LUAD patientsBack to article page